Stock Market News3 days Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales Zacks
BHC’s fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.
XBHC’s fourth-quarter adjusted earnings and revenues beat estimates driven by Xifaxan. The guidance for 2025 is positive.
X